He was born in 1963 in Eger, Hungary. He earned his university degree at Eötvös Loránd University (ELTE). As a research fellow, he studied and conducted research at Oxford University and Brandeis University in Boston. He obtained his Ph.D. (Candidate of Chemical Sciences) in 1995. He completed his postdoctoral research at the Wistar Institute in Philadelphia (USA), then became a senior scientist at Neurex, a biotechnology company in Silicon Valley (Menlo Park, CA), where he worked on drug discovery and development projects targeting neurological diseases.
Between 1998 and 2001, he led preclinical drug development at Biorex Ltd. From 2001 to 2006, he served as CEO of ComGenex Inc., winner of the Hungarian Innovation Grand Prize. Under his leadership, the company was acquired by AMRI (USA). From 2006 to 2012, he was CEO of ThalesNano, where he participated in the development of the H-Cube technology, which won the Innovation Oscar Award. During his tenure, the technology was adopted by the world’s 20 leading pharmaceutical companies and research institutes across 35 countries on 5 continents.
Since 2012, he has been Director of Business Development at ComInnex Inc., where he has led the development of new drug discovery technology platforms and their successful implementation in the global pharmaceutical industry. He is co-founder and board member of several internationally successful research and development companies. He is co-author of 110 publications, patents, and book chapters, and an honorary professor at the University of Pannonia.
